Regular, consistent physical activity just might help reduce the symptoms of certain urological health issues, including urinary incontinence and erectile problems.

There is an abundance of evidence that the human microbiome plays an important and nuanced role in controlling human health, including metabolism, immunity, pain, psychological state, and cancer.

The role of genetic testing for prostate cancer risk is a rapidly changing area. Experts debate the indications of sending a patient on to genetic counseling for further potential screening for inherited prostate cancer risk. One major issue that needs to be addressed in the urology community today is recognizing the frequency of inherited mutations that are affecting prostate cancer patients.

Latest prostate cancer research is turning its focus on the M0 space. Many therapeutic options for castration-resistant prostate cancer are approved and used for metastatic castration-resistant prostate cancer (mCRPC), but fewer options exist for those with non-metastatic (NM) CRPC.

The role of imaging is paramount in this evolution by providing physicians with accurate information on both the presence and extent of prostate cancers. Developments in molecular imaging are paving the way for more physicians to diagnose cancer and apply relevant therapy.

One of the major treatments for prostate cancer is androgen-deprivation therapy (ADT), and about 50% of prostate cancer patients are treated with ADT at some point in their disease. ADT is used most frequently for patients with local but advanced prostate cancer or metastatic prostate cancer.

Nocturia is arguably the most bothersome lower urinary tract symptom and necessarily imposes a considerable burden on quality of life. The often-multifactorial etiologies contributing to nocturia obscure the establishment of a reliable diagnosis.

Upper tract urothelial carcinoma (UTUC) is cancer of the transitional urothelial cells that line the upper urothelial tract of the renal pelvis and ureter. This type of cancer accounts for between 5% and 10% of urothelial cancer cases.

There is no excerpt because this is a protected post.

In a GRU exclusive, Laurence Klotz, MD, FRCSC, Professor of Surgery and holder of the Sunnybrook Chair of Prostate Cancer Research at the University of Toronto, gives three Platinum Lectures on the current state of active surveillance for prostate cancer.

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

These lectures were presented during the Perspectives in Urology Point • Counterpoint Virtual Conference on November 11, 2020.

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

The 2020 Virtual Southwest Prostate Cancer Symposium (SPCS 2020) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices.

These lectures were presented during the 2020 Virtual Future Directions in Urology Symposium on August 10, 2020.

The goal of this educational program is to equip urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in prostate cancer care with the up-to-date clinical knowledge and tools they need to best treat their patients.

Dr. Pohlman is a urologist with Kearney Urology Center, P.C., in Kearney, Nebraska. On the Prostate Health Podcast, Dr. Pohlman conducts weekly interviews with experts, innovators, and leaders regarding prostate conditions.

Neil H. Baum, MD, is a Clinical Professor of Urology at Tulane Medical School in New Orleans, Louisiana. In this series, Dr. Baum presents quick tips on a variety of timely, relevant topics for the practicing urologist.

These lectures were presented during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.